List of Vanos drug patents

Vanos is owned by Bausch.

Vanos contains Fluocinonide.

Vanos has a total of 3 drug patents out of which 3 drug patents have expired.

Expired drug patents of Vanos are:

  • US7794738
  • US7220424
  • US8232264

Vanos was authorised for market use on 11 February, 2005.

Vanos is available in cream;topical dosage forms.

Vanos can be used as relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 years of age or older.

The generics of Vanos are possible to be released after 09 March, 2023.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7794738 BAUSCH Compositions and methods for enhancing corticosteroid delivery
Sep, 2022

(6 months ago)

US7220424 BAUSCH Compositions and methods for enhancing corticosteroid delivery
Jan, 2023

(2 months ago)

US8232264 BAUSCH Compositions and methods for enhancing corticosteroid delivery
Mar, 2023

(24 days ago)

Drugs and Companies using FLUOCINONIDE ingredient

Market Authorisation Date: 11 February, 2005

Treatment: Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 12 years of age or older

Dosage: CREAM;TOPICAL

How can I launch a generic of VANOS before it's patent expiration?
More Information on Dosage

VANOS family patents

9

United States

2

Japan

2

European Union

1

Brazil

1

Canada

1

Mexico

1

Australia

1

China

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic